Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cerus Corporation (CERS : NSDQ)

• Company Description    Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. Number of Employees: 281

• Price / Volume Information    Yesterday's Closing Price: $1.23 Daily Weekly Monthly 20 Day Moving Average: 1,113,494 shares Shares Outstanding: 191.70 (millions) Market Capitalization: $235.79 (millions) Beta: 1.63 52 Week High: $2.24 52 Week Low: $1.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.15% -4.85% 12 Week -8.21% -16.62% Year To Date -20.13% -27.53%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1220 CONCORD AVENUE SUITE 600 - CONCORD,CA 94520 USA ph: 925-288-6000 fax: 925-288-6001 ir@cerus.com http://www.cerus.com

• General Corporate Information    Officers William M. Greenman - President; Chief Executive Officer and Director Daniel N. Swisher - Director and Chair of the Board of Directors Kevin D. Green - Vice President; Finance and Chief Financial Offic Eric H. Bjerkholt - Director Dean A. Gregory - Director Peer Information Cerus Corporation (BJCT) Cerus Corporation (CADMQ) Cerus Corporation (APNO) Cerus Corporation (UPDC) Cerus Corporation (IMTIQ) Cerus Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 157085101 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 10/29/25 Share - Related Items Shares Outstanding: 191.70 Most Recent Split Date: (:1) Beta: 1.63 Market Capitalization: $235.79 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.12 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/29/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.20 Price/Cash Flow: - Price / Sales: 1.22 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: 25.00% Sales Growth vs. Year Ago Period: 16.34% vs. Previous Quarter: 21.29% ROE 06/30/25 - -33.77 03/31/25 - -34.81 12/31/24 - -39.53 ROA 06/30/25 - -9.32 03/31/25 - -9.68 12/31/24 - -10.94 Current Ratio 06/30/25 - 2.00 03/31/25 - 2.32 12/31/24 - 2.39 Quick Ratio 06/30/25 - 1.35 03/31/25 - 1.63 12/31/24 - 1.79 Operating Margin 06/30/25 - -9.81 03/31/25 - -10.23 12/31/24 - -11.60 Net Margin 06/30/25 - -9.81 03/31/25 - -10.23 12/31/24 - -11.60 Pre-Tax Margin 06/30/25 - -9.66 03/31/25 - -10.15 12/31/24 - -10.31 Book Value 06/30/25 - 0.29 03/31/25 - 0.29 12/31/24 - 0.31 Inventory Turnover 06/30/25 - 1.91 03/31/25 - 2.05 12/31/24 - 2.14 Debt-to-Equity 06/30/25 - 1.01 03/31/25 - 1.15 12/31/24 - 1.14 Debt-to-Capital 06/30/25 - 50.26 03/31/25 - 53.56 12/31/24 - 53.27

Powered by Zacks Investment Research ©